The strength of our team is in it's balanced expertise in both Life Sciences and Computer Sciences Our Team

FirstMark Rogers, MSc Cofounder & CEO 15yrs+ in Emerging Biotech Business Development, Cell & Gene Therapy Research & Protein-Protein Interaction Screening. MSc in Molecular Biotechnology. Previously Associate Director- Emerging Biotech at Merck KGaA & Cofounder of Curogenix SecondPavel Kartasevs, MEng Cofounder & CTO 10yrs experience in High-Performance Computing, Machine Learning, NLP, Bioinformatics & Software Engineering. MEng in Computer Engineering, MSc in Bioinformatics. Previously Tech Lead at UK Tech Start-up & Tutor in Bioinformatics at Cranfield University. ThirdAnna O'Leary, BA Cofounder & COO 10yrs experience in Business Operations. BA in Business & Finance. Previously worked in management at Aramark, and in operations at RBS Global Banking & Markets (US) and at Aramark. FourthJohn Conway, MSc Head of Machine Learning Research 20yrs in hands-on Data Analytics and Machine Learning research, and management of data science teams. MSc in Data Science. Previously, Director of Data Science at a FinTech startup. FifthDavid Kwon, MD, PhD, MBA Advisor - Clinical Development & Digital Strategy Currently, Executive Director of Clinical Development at Esperion. Previously, Global Medical Director at Novartis & Gilead. SixthProf. Jody Haigh, PhD Advisor - Oncology Pharmacology & Therapeutics Professor of Pharmacology & Therapeutics, Haematological Oncology, CancerCare Manitoba. Previously worked at Monash University, Ghent University and the Research Institute of Molecular Pathology (IMP) in Vienna. SeventhBill Allison Advisor - Business Strategy & Technology Chief Technology Officer at UC Berkeley. Berkeley Skydeck Advisor. EightNiranjan Tulpule, BEng Advisor & Investor - Knowledge graphs and software development Engineering Director at Google NinthSam Mercer, BSc Consultant - Strategy & Business Development Consultant, and Board Chairperson Vancouver Island Life Sciences. Previously, worked in clinical trial outsourcing at Novartis and Roche, and business development at Eupraxia.